Detailansicht

Wissensnetz

Person

Stefan Pusch (1979-)

Biologe

Name	Stefan Pusch
Zeit	1979- (Lebensdaten)
Ort	Karlsruhe (Geburtsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	PD Dr. rer. nat.
Beruf	Biologe (charakteristischer Beruf)
Variante	Stefan René Pusch
Beziehung	Deutsches Krebsforschungszentrum Universitätsklinikum Heidelberg
Weitere Angaben	Mitarbeiter der Klinischen Kooperationseinheit Neuropathologie des DKFZ, Neuropathologie, Universitätsklinikum Heidelberg
Datensatztyp	Person
GND-Nummer	137014155
Datensatz-ID	137014155
Beteiligt an alle anzeigen EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma Dysfunctional dendritic cells limit antigen-specific T cell response in glioma PFKFB4 interacts with FBXO28 to promote HIF-1α signaling in glioblastoma Prohibitin, STAT3 and SH2D4A physically and functionally interact in tumor cell mitochondria Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesis Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomas Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA CIC protein instability contributes to tumorigenesis in glioblastoma RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomas Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometry Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KG Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KG Interaktionsanalyse von CDKA;1 und anderen Zellzyklusregulatoren aus Arabidopsis thaliana Interaktionsanalyse von CDKA;1 und anderen Zellzyklusregulatoren aus Arabidopsis thaliana

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Stefan Pusch (1979-)

EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma

Dysfunctional dendritic cells limit antigen-specific T cell response in glioma

PFKFB4 interacts with FBXO28 to promote HIF-1α signaling in glioblastoma

Prohibitin, STAT3 and SH2D4A physically and functionally interact in tumor cell mitochondria

Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation

NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesis

Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer

RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomas

Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p

Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA

CIC protein instability contributes to tumorigenesis in glioblastoma

RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomas

Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate

Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometry

Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo

Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KG

Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KG

Interaktionsanalyse von CDKA;1 und anderen Zellzyklusregulatoren aus Arabidopsis thaliana

Interaktionsanalyse von CDKA;1 und anderen Zellzyklusregulatoren aus Arabidopsis thaliana